Our research on how ketamine prevents depression was published on Molecular Psychiatry

Illustration: Getty Images

The discovery that the anaesthetic ketamine can help people with severe depression has raised hopes of finding new treatment options for the disease. Researchers at Karolinska Institutet have now identified novel mechanistic insights how the drug exerts its antidepressant effect. The findings have been published in the journal Molecular Psychiatry.

https://news.ki.se/new-findings-on-how-ketamine-prevents-depression